Recent Finacing
Recent Raise
Amber Bio develops an RNA editing platform for multi-kilobase, durable, reversible RNA corrections to address genetically diverse diseases and advances in-house genetic medicine programs from its San Francisco base.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Amber Bio.
